enVVeno Medical Corporation
NVNO
$2.19
$0.073.30%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.27% | -12.82% | 23.45% | 21.90% | 8.59% |
| Total Depreciation and Amortization | -8.96% | -6.52% | -1.45% | 3.68% | 3.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.61% | 5.28% | -6.35% | -29.24% | -39.51% |
| Change in Net Operating Assets | 80.88% | 180.81% | -106.13% | 162.50% | -604.32% |
| Cash from Operations | -2.65% | -1.50% | 14.35% | 30.53% | -28.97% |
| Capital Expenditure | 0.00% | -200.00% | 33.33% | -100.00% | 55.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.08% | 40.04% | -43.23% | -22.07% | -500.72% |
| Cash from Investing | 50.07% | 39.93% | -43.26% | -22.29% | -501.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,118.78% | 6,596.12% | -97.30% | 42.77% | -179.88% |
